University of Oxford

Diseases, Conditions, Syndromes

Oral paratyphoid vaccine to begin human trials

The University of Oxford in collaboration with the University of Maryland School of Medicine (UMSoM) has begun recruiting for a Phase I/II trial of a new paratyphoid vaccine in human volunteers in Oxford.

Diseases, Conditions, Syndromes

Rabies vaccine candidate begins human trials in Tanzania

The University of Oxford and the Ifakara Health Institute today announced the vaccination of the first participants in a Phase Ib/II trial testing a novel rabies vaccine in human volunteers in Tanzania.

Diseases, Conditions, Syndromes

COVID-19 Multi-Omic Blood Atlas (COMBAT) published

A multi-disciplinary, cross-divisional collaborative team led by the University of Oxford has published a study defining hallmarks of COVID-19 disease severity. The team, led by Professor Julian Knight at the Wellcome Centre ...

Diseases, Conditions, Syndromes

Review highlights impact of long COVID on cardiovascular system

The wide-ranging effects of long COVID and the associated issues for healthcare providers have been revealed in a new review of the major studies into the condition, which specifically highlights the impact of Long COVID ...

page 15 from 40